2 completed, 1 recruiting. 3 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 2, Recruiting 1 |
| Phase 1 | 1 | Completed 1 |
Follow Non-metastatic Prostate Cancer: new trials by email Literature Review of Non-metastatic Prostate Cancer trials Research Report on Non-metastatic Prostate Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Radiation Therapy Approaches for People With Prostate Cancer Standard of Care HDR Brachytherapy, SBRT - Prostate Cancer Patients, Non-metastatic Prostate Cancer | Phase 2 | Recruiting | Memorial Sloan Kettering Cancer Center | 126 | 2026-07-31 | 2026-08-12 |
| Androgen Receptor Directed Therapy on Cognitive Function in Patients Treated With Darolutamide or Enzalutamide Darolutamide, Enzalutamide - Metastatic Prostate Cancer, Prostate Cancer Metastatic | Phase 2 | Completed | Alliance Foundation Trials, LLC. | 111 | 2021-08-17 | 2026-09-21 |
| Safety Study to Explore Combination of Gefitinib (ZD1839, Iressa) and Radiotherapy in Non-Metastatic Prostate Cancer Gefitinib, radiotherapy - Non-Metastatic Prostate Cancer | Phase 1 / Phase 2 | Completed | AstraZeneca | 42 | 2003-01-01 | 2009-04-23 |
Genital Diseases (2) · Genital Diseases, Male (2) · Genital Neoplasms, Male (2) · Male Urogenital Diseases (2) · Neoplasms (2) · Neoplasms by Site (2) · Prostatic Diseases (2) · Urogenital Diseases (2) · Urogenital Neoplasms (2)
Gefitinib (1) · Radiotherapy (1) · darolutamide (1) · enzalutamide (1)
Alliance Foundation Trials, LLC. (1) · AstraZeneca (1) · Memorial Sloan Kettering Cancer Center (1)
United States (2) · Finland (1)
Daniel Gorovets, MD (1) · Evanthia Galanis, MD (1)